Literature DB >> 6179076

Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells.

M Fellous, U Nir, D Wallach, G Merlin, M Rubinstein, M Revel.   

Abstract

In human cells treated with interferons, there is an increase in the amount of HLA-A,B,C and beta 2-microglobulin exposed on the cell surface. We have used a cloned HLA-A,B,C cDNA probe to demonstrate by molecular hybridization that this effect of interferon is preceded by a large increase in the amount of HLA mRNA in the cell. This effect was found in five different human cell lines, with purified leukocyte and fibroblast interferons. The increase in HLA mRNA is comparable in its kinetics and dose-response to the induction of (2'-5') oligo(A) synthetase mRNA by interferons. Therefore, interferons seem to activate at least two cellular genes which have different biochemical functions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6179076      PMCID: PMC346357          DOI: 10.1073/pnas.79.10.3082

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Production of beta 2-microglobulin by normal and malignant human cell lines and peripheral lymphocytes.

Authors:  K Nilsson; P E Evrin; K I Welsh
Journal:  Transplant Rev       Date:  1974

2.  Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.

Authors:  G Klein; L Dombos; B Gothoskar
Journal:  Int J Cancer       Date:  1972-07-15       Impact factor: 7.396

3.  Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

Authors:  E Klein; G Klein; J S Nadkarni; J J Nadkarni; H Wigzell; P Clifford
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

4.  Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes.

Authors:  P Lindahl; P Leary; I Gresser
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

5.  Cytotoxicity of a factor isolated from human spleen.

Authors:  C B Lozzio; B B Lozzio
Journal:  J Natl Cancer Inst       Date:  1973-02       Impact factor: 13.506

6.  Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon.

Authors:  A Adams; H Strander; K Cantell
Journal:  J Gen Virol       Date:  1975-08       Impact factor: 3.891

7.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

8.  Susceptibility of human diploid fibroblast strains to transformation by SV40 virus.

Authors:  G J Todaro; H Green; M R Swift
Journal:  Science       Date:  1966-09-09       Impact factor: 47.728

9.  Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells.

Authors:  P Lindahl; P Leary; I Gresser
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

10.  Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines.

Authors:  G Klein; J Zeuthen; P Terasaki; R Billing; R Honig; M Jondal; A Westman; G Clements
Journal:  Int J Cancer       Date:  1976-11-15       Impact factor: 7.396

View more
  79 in total

1.  Molecular cloning of gene sequences regulated during squamous differentiation of tracheal epithelial cells and controlled by retinoic acid.

Authors:  H L Smits; E E Floyd; A M Jetten
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

2.  Expression of MHC class II antigens by conjunctival epithelial cells in trachoma: implications concerning the pathogenesis of blinding disease.

Authors:  D C Mabey; R L Bailey; D Dunn; D Jones; J H Williams; H C Whittle; M E Ward
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

Review 3.  Interferon-zeta/limitin: novel type I interferon that displays a narrow range of biological activity.

Authors:  Kenji Oritani; Yoshiaki Tomiyama
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

4.  A transposable epitope of HLA-B7, B40 molecules.

Authors:  J P Ways; D A Lawlor; A M Wan; P Parham
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

5.  Natural killer susceptibility of human cells may be regulated by genes in the HLA region on chromosome 6.

Authors:  A Harel-Bellan; A Quillet; C Marchiol; R DeMars; T Tursz; D Fradelizi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

Review 6.  Interferons: current status and future directions of this prototypic biological.

Authors:  R V Smalley; E C Borden
Journal:  Springer Semin Immunopathol       Date:  1986

7.  Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.

Authors:  H H Nguyen; F W van Ginkel; H L Vu; M J Novak; J R McGhee; J Mestecky
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

8.  Transfected rat islet tumour cells express mouse major histocompatibility complex class I antigens functionally. Applicable as "pseudo-syngeneic" targets in the multiple low-dose streptozotocin diabetes model.

Authors:  P Serup; J Schøller
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

9.  Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts.

Authors:  T Collins; A J Korman; C T Wake; J M Boss; D J Kappes; W Fiers; K A Ault; M A Gimbrone; J L Strominger; J S Pober
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

10.  Autocrine induction of major histocompatibility complex class I antigen expression results from induction of beta interferon in oncogene-transformed BALB/c-3T3 cells.

Authors:  M K Offermann; D V Faller
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.